GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere

NCT00274287 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: GM CSF

Sponsor

Oncology Specialists, S.C.

Collaborators

[object Object]